This trial is testing whether using a needle-based laser to get real-time images of tissue during a bronchoscopy, along with the dye fluorescein, is better than just using the bronchoscopy alone for diagnosing lung cancer in patients with peripheral pulmonary nodules.
- Lung Cancer
1 Primary · 1 Secondary · Reporting Duration: Up to 2 years
Awards & Highlights
2 Treatment Groups
Arm I (EBUS TBNA)
1 of 2
Arm II (EBUS TBNA, nCLE, fluorescein)
1 of 2
118 Total Participants · 2 Treatment Groups
Primary Treatment: Arm II (EBUS TBNA, nCLE, fluorescein) · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is recruitment still underway for this experiment?
"According to clinicaltrials.gov, the posting for this trial is no longer accepting patients; it was first uploaded on December 15th 2022 and last updated November 29th 2022. Nonetheless, there are 1507 other studies actively recruiting at present." - Anonymous Online Contributor